Altre lingue Sichuan Huiyu Pharmaceutical Co., Ltd.

Azioni

688553

CNE100004ZT4

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 10/07/2024			Variaz. 5gg	Var. 1 gen.
11,64 ^CNY	-0,17%		-6,58%	-23,07%

28/06	L'unità farmaceutica Huiyu ottiene l'autorizzazione a commercializzare tre farmaci antitumorali in Uzbekistan	MT
26/04	Sichuan Huiyu Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Huiyu Pharmaceutical Unit Gets Nod to Market Three Cancer Drugs in Uzbekistan	28/06
France Grants Marketing Approval for Huiyu Pharma's Osteoporosis Injection	20/06
Tranche Update on Sichuan Huiyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 24, 2024.	23/05
Sichuan Huiyu Pharmaceutical Co., Ltd.'s Equity Buyback announced on February 24, 2024, has closed with 2,139,878 shares, representing 0.51% for CNY 30.01 million.	23/05
China Grants Drug Registration for Huiyu Pharma's Two Injectables	15/05
Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Sichuan Huiyu Pharmaceutical Gets Chinese FDA Nod for Methotrexate Anti-Tumor Injection	17/04
Tranche Update on Sichuan Huiyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 24, 2024.	02/04
Huiyu Pharma Unit Gets Libya's Marketing Approval for Cancer Drug	06/03
Huiyu Pharma Gets China Registration Approval for Cancer Drug	05/03
US FDA Grants New Drug Application to Huiyu Pharma's Cancer Injection	05/03
Sichuan Huiyu Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.	24/02
Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Sichuan Huiyu Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	23/02
Three Drugs of Huiyu Pharma's Unit Gets Greenlight to Enter Egyptian Market	21/02
Huiyu Pharma's Unit Gets Greenlight to Enter UK Market	19/02
Huiyu Pharmaceutical's Subsidiary Administers First Patient for Tumor Drug Trial; Shares Drop 5%	05/02
TYK Medicines, Inc. announced that it has received funding from Sichuan Huiyu Pharmaceutical Co., Ltd., CICC Capital Management Co., Ltd., Zhejiang Changxing Financial Holding Group Co., Ltd., and other investors	28/12
Huiyu Pharma Passes US FDA Inspection	19/12
Chengdu Houhan Technology Co., Ltd. and Beijing Houhong Technology Co., Ltd. agreed to acquire 49.9% stake in Sichuan Huiyu Yueying Pharmaceutical Technology Co., Ltd. from Sichuan Huiyu Pharmaceutical Co., Ltd. for CNY 16.6 million.	15/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Sichuan Huiyu Pharmaceutical Co., Ltd.

Azioni

688553

CNE100004ZT4

Altre lingue

Filtri